logo

ICPT(Delisted)

Intercept PharmaceuticalsยทNASDAQ
--
--(--)

ICPT Profile

Intercept Pharmaceuticals, Inc.

A biopharmaceutical company focused on novel therapeutics to treat chronic liver disease

--
09/04/2002
10/11/2012
NASDAQ Stock Exchange
341
12-31
Common stock
305 Madison Avenue, Morristown, NJ 07960
--
Intercept Pharmaceuticals, Inc., incorporated in Delaware on September 4, 2002, is a development-stage pharmaceutical company focused on the development and sale of novel therapies for chronic liver diseases using its proprietary bile acid chemistry. The company's products have therapeutic potential for the treatment of isolated, prevalent liver diseases, for which there are still limitations.